Michael Gelband’s Arcellx ACLX Stock Holding History

Michael Gelband’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,828	Closed	-$1.7M	–	1517
2026 Q1	$1.7M	Sell	14,828 -202,596	-93%	-$17.9M	0.01%	844
2025 Q4	$14.2M	Buy	217,424 +207,978	+2,202%	+$16.6M	0.11%	165
2025 Q3	$776K	Buy	+9,446	New	+$680K	0.01%	1045
2023 Q4	–	Sell	-37,952	Closed	-$1.36M	–	1405
2023 Q3	$1.36M	Buy	+37,952	New	+$1.31M	0.01%	838
2022 Q3	–	Sell	-64,021	Closed	-$1.16M	–	1828
2022 Q2	$1.16M	Buy	+64,021	New	+$826K	0.01%	1011

Other funds holding ACLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Michael Gelband's ACLX Position: Q2 2026 in Review

Michael Gelband sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 14,828 shares — an estimated $1.7M sold.

Michael Gelband first reported a position in ACLX in Q2 2022 and held it in 5 quarters. The position peaked at $14.2M in Q4 2025. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

Michael Gelband reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
Michael Gelband sold 14,828 Arcellx shares in Q2 2026, an estimated $1.7M.
Michael Gelband first reported a position in Arcellx in Q2 2022 and held it in 5 quarters.
Michael Gelband's Arcellx position peaked at $14.2M in Q4 2025.
2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.